GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Question] 503B — what am I missing here — 31 comments in the full submission. View in context.
405
c/compounding·submitted 7 months ago by u/quiet_moderator

[Question] 503B — what am I missing here

Questionbranch of 15 comments

Confession thread, sort of. I went from 15mg to 7.5mg much faster than I should have because the scale had stalled and I got impatient. The stall broke about 23 weeks later, at which point I had no way of knowing whether the dose increase did anything or whether it would have broken anyway. So now I have sulphur…

Read the full submission and all 31 comments →

This branch

15 comments, started 7 months ago
u/formulary_fighterappeals35 points·7 months ago

Asked 14 compounders about API source. One told me, one dodged, one said they cannot say. The answer is the signal.

replysharereportpermalink
u/sofia_danquah24 points·7 months ago

shortage list status is 503A, check the actual list

replysharereportpermalink
u/formulary_fighterappeals6 points·7 months ago

Are we talking 503A or 503B?

replysharereportpermalink
u/pavel_kravchenko8 points·7 months ago·edited

This is correct. The shortage list does expire and the rules change.

replysharereportpermalink
u/lipid_panel_larrybloodwork-7 points·7 months ago

503B compounding is different from 503A, different rules, different legality

replysharereportpermalink
u/camila_mensa27 points·7 months ago

Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.

replysharereportpermalink
u/kian_ferreira14 points·7 months ago

telehealth costs 503A plus compounding markup, total varies

replysharereportpermalink
u/quiet_moderatorOPmod8 points·7 months ago

Slight fix: the number was 97.9, not 97.6. Decimal point, but a fairly consequential one.

replysharereportpermalink
u/rohan_steiner4 points·7 months ago

the shortage list is temporary, it ends and compounding becomes illegal again

replysharereportpermalink
u/camila_sandvik1 point·7 months ago·edited

503B compounding is different from 503A, different rules, different legality

replysharereportpermalink
u/usp_appendixcompendial5 points·7 months ago

telehealth prescriber models exist, pricing differs by state

replysharereportpermalink
u/draw_up_dizzy4 points·7 months ago·edited

This is correct. The shortage list does expire and the rules change.

replysharereportpermalink
u/maren_sorensen0 points·7 months ago

Slight fix: the number was 98.7, not 98.6. Decimal point, but a fairly consequential one.

replysharereportpermalink
u/honest_syringe_202513 points·7 months ago

regulatory claims need a citation to the actual rule, not interpretation

replysharereportpermalink
u/formulary_fighterappeals21 points·7 months ago·edited

Sceptical. If this were true we would see it reflected in the data and we do not.

replysharereportpermalink

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.